Clinical Trials Sponsored by Q2i, LLC

Total 11361 results

Q2i, LLC
National Institute on Drug Abuse (NIDA); University of Massachusetts, Worcester

Recruiting

Reward-based Technology to Improve OUD Treatment (OARSCM)

Opioid Use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of Massachusetts, Worcester

Completed

Usability Testing for the Reward-based Technology to Improve OUD Treatment (OARSCM)

Contingency Management | Opioid-use Disorder | Medication for Opioid-use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Enrolling by invitation

Technology for MAT in Primary Care - Phase 2

Opioid-use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Completed

Technology for MAT in Primary Care - Phase 1

Opioid-use Disorder

United States
BHR Pharma, LLC
Q2 Solutions; H2O Clinical LLC

Terminated

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel (MASTERS)

Cancer of the Prostate

United States
Vaxess Technologies
ICON plc; Q2 Solutions; Centricity Research

Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Influenza

Canada
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
LLS PedAL Initiative, LLC
Kura Oncology

Recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Relapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia

United States, Canada
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
Qi Yu

Completed

The Main Content of This Study is to Use Virtual Reality Technology Combined With Local Anesthesia With Lidocaine Injection at Different Times to Reduce the Pain of PICC in School-age Children

Catheterization, Peripheral

China
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
Massachusetts General Hospital
C2i Genomics; Spier Family Foundation

Not yet recruiting

ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Rectal Cancer | Non Metastatic Rectal Cancer

United States
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
Gustave Roussy, Cancer Campus, Grand Paris
BeiGene; C2i Genomics

Not yet recruiting

tislelizUMaB in canceR Patients With molEcuLar residuaL Disease (UMBRELLA)

Soft Tissue Sarcoma | Cancer | Lung Cancer | Pancreas Cancer | Colo-rectal Cancer

France
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
IVFarma LLC
NADIM LLC

Completed

The Safety and Pharmacokinetics of Primapur and Gonal-f

Pharmacokinetics | Absorption | Area Under Curve

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

Healthy Adults

Russian Federation
Immunitor LLC
Ekomed LLC

Unknown

Open Label Immunotherapy of Endometriosis

Endometriosis

Mongolia
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Qi-Yong Li

Completed

Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique

Biliary Diseases | Pancreas Diseases

China
Sonablate
Vascular Care CT, PLLC; Vascular Breakthroughs, LLC

Recruiting

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery (HIFIVE)

Venous Leg Ulcers | Venous Malformations | CLOVES Syndrome | Blue Rubber Bleb Nevus Syndrome | Klippel-Trenaunay Syndrome | Chronic Venous Insufficiency, CVI

United States
Monsoon Design Studio LLC
Healthark Wellness Solutions LLP

Completed

Study of Evoked Emotional Responses

Emotion, Expressed

India
AOBiome LLC
bioRASI, LLC

Completed

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Pruritus | Atopic Dermatitis

United States
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
AOBiome LLC
bioRASI, LLC

Completed

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

Rosacea

United States
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
BioMendics, LLC
Symbio, LLC

Completed

Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

Wound Healing

United States
Pharmtechnology LLC
ClinPharmInvest, LLC

Unknown

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions

Bioequivalence

Russian Federation
Soniphi LLC
UserWise, LLC

Unknown

Vocal Feature Analysis Algorithm for COVID-19 Detection

COVID-19

United States
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions

Healthy Adults

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg/5ml and Nurofen®, Oral Suspension 100 mg/5 ml in Healthy Volunteers Under Fasting Conditions

Healthy

Russian Federation
Galvani Bioelectronics
NAMSA; Q2 Solutions

Recruiting

ConsideRAte Study - Splenic Stimulation for RA

Rheumatoid Arthritis

United States, Netherlands
Amneal Pharmaceuticals, LLC
Symbio, LLC

Completed

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Uncomplicated Urinary Tract Infections

United States
Cristcot LLC
Cristcot HCA LLC

Completed

Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Ulcerative Proctitis

United States
Pharmtechnology LLC
Ligand Research, LLC

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
PHARMENTERPRISES LLC
RSV Therapeutics LLC

Completed

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

Influenza | Acute Respiratory Viral Infections

Russian Federation
Nearmedic Plus LLC
OCT LLC

Completed

Phase 1 Study of PBTZ169

Tuberculosis
Corium, Inc.
Premier Research Group plc; Almac; Prometrika, LLC

Completed

An Efficacy and Safety Study w/ Azstarys® in Children With ADHD (KP415P01)

Attention Deficit/Hyperactivity Disorder

United States
Pharmtechnology LLC
Ligand Research, LLC

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Padagis LLC
Impax Laboratories, LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Atrophy

United States
Saptalis Pharmaceuticals LLC
bioRASI, LLC

Completed

A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

Scabies

United States

Clinical Trials Sponsored by Q2i, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations